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narrow the number of genes that orchestrate cartilage regeneration (and
ear-wound healing) and may inform the likelihood of cartilage healing
in patients.
Fig. 2. Mean histological score for cartilage defects in healer and non-
healer strains.
Fig. 3. Mean ear-wound diameter ﬁlled in healer and non-healer strains.
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Purpose: Osteochondral defect is followed by a ﬁbrocartilage tissue
repairing that present weak mechanical properties faced to native
cartilage tissue. Until now, few strategies attempt to repair osteochondral
defects; and generally, cartilage and bone tissues are study separately
for repairing only focal lesions. However, some ways lead to obtain a
stratiﬁed scaffold to repair the whole cartilage thickness or osteochondral
defect by taking in account the depth-dependant variation of cells
phenotype, and matrix composition and organization. Our work aimed
at contributing to stratiﬁed tissue engineering with providing an original
scaffolds composition of an hydrogel seeded with human Mesenchymal
Stem Cells from Bone Marrow (hBM-MSCs). The biomaterial used is based
on sodium Alginate supplemented with Hyaluronic Acid (Alg/HA) in a
layer and with Hydroxyapatatite (Alg/Hap) in the other layer to mimic
osteochondral matrix composition to target cells differentiation. Indeed,
it is admitted that scaffold composition and mechanical properties
inﬂuence cell phenotype.
Methods: A stratiﬁed hydrogel was build up by a simple and progressive
spray of cellular gel suspension alternate with polyelectrolyte multilayer
(PEMs) to weld layers. hBM-MSCs were embedded in an Alg/Hap gel,
then sprayed and the biomaterial was gelled in a CaCl2 bath. Then,
PEMs were built up on the hydrogel and a second hydrogel layer was
constructed as previously, with an Alg/HA gel seeded with hBM-MSCs.
We had evaluated cells comportment in the layered scaffolds cultured
with a basic chondrogenic medium, without growth factor. In fact, we had
checked cells proliferation by following cell cycle and explored matrix
synthesis at 28 days of culture to evaluate hBM-MSCs differentiation, by
histological and confocal microscopy observations.
Results: Previously, we built up stratiﬁed scaffold with Alg/HA in all
layers and we had a good cohesion of layers up to 56 days of in
vitro culture, and a matrix synthesis of which the type II collagen
speciﬁc from cartilage tissue. We changed the bottom layer composition
(ﬁrst sprayed) to obtain different cells differentiation. We still observed
good cohesion during the culture time. Moreover, we checked cells
proliferation during 28 days, and we observed that cells stop it after their
embedding in the hydrogel; indeed, they were most in G0/G1 phase.
In addition, we checked extracellular matrix synthesis by histological,
and by ﬂuorescent labeling observed in confocal microscopy. In the
two hydrogel compositions, we observed type II and type X collagens
which are typically synthesized by chondrocytes and hypertrophic
chondrocytes, respectively.
Conclusions: Here, we showed that we are able to construct bistratiﬁed
scaffolds with two different hydrogel compositions and to induce
a chondrogenic differentiation without biochemical or mechanical
stimulations. In a near vision, challenge is to create a tristratiﬁed scaffolds
to mimic more precisely cartilage layers and the sub-chondral bone layer
by improving hydrogel composition to targeted cells differentiation.
Moreover, PEMs are known to adsorb proteins as growth factor, this
way can be explored to evaluate growth factor local delivery on cells
phenotype. In a long term sight, those scaffolds can be implanted in
osteochondral defect in animals to restore the tissue integrity to avoid
its degeneration.
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Purpose: Bone morphogenetic protein 7 (BMP-7) has a strong anabolic
effects on cartilage by stimulating the matrix synthesis. Therefore,
BMP-7 is expected to be a target of pharmacotherapy for cartilage
diseases. However, maintenance of effective concentration of proteins
is difﬁcult because usual proteins are metabolized immediately when
direct administration into joints is performed. We previously reported
the sustained releasing system of basic ﬁbroblast growth factor had the
therapeutic effects on experimental osteoarthritis (OA) in the rabbit knee.
In this study, BMP-7 was administered into joints of OA rabbit models by
sustained releasing system, and the protective effect on OA development
was investigated.
Methods: Biodegradable gelatin hydrogel microspheres (GHM) were
prepared for the controlled release of BMP-7. The average diameter
was 70mm.
125I labeled BMP-7 contained in GHM was administered into the knee
joints of normal rabbits to conﬁrm the sustained release kinetics of the
impregnated BMP-7 in the knee joint. The persistent radio-activities
in the knee joint (n =3) were measured 1, 3, 7 and 14 days after
administration.
Thirty Japanese white rabbits underwent unilateral anterior cruciate
ligament transaction (ACLT).One mg BMP-7 with GHM (BMP-M group),
one mg BMP-7 solution (BMP-S group) and PBS (PBS group) were injected
into the ACLT knee joints once three weeks (a total of twice) from
4 weeks after ACLT. Ten weeks after ACLT, gross morphological (score
0–5) examinations were performed.
All ACLT knees were evaluated for gross morphological changes 10 weeks
after ACLT and classiﬁed into 6 grades [Grade 1 (intact articular surface),
2, 3, 4a, 4b and 4c (severely degenerated articular surface)] by using
India ink and the grade was scored from 0 to 5. Synovium and cartilage
were harvested from the evaluated knee and examined histologically.
Results: The amount of labeled BMP-7 that remained in the knee joint
was signiﬁcantly larger in rabbits administered labeled BMP-7with GHM
than in those administered labeled BMP-7-solution for 7 days. This
showed that sustained-releasing of BMP-7 in the knee joint continued
for over 7 days.
Severely damaged cartilage (Grade 4a, 4b, and 4c) was observed in 50% of
PBS group, in 30% of BMP-S group and in 10% of BMP-M group. Averaged
scores in PBS group, BMP-S group, and BMP-M group were 2.4, 1.5 and
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0.9, respectively. The scores of cartilage damage in the BMP-M group
were less severe than PBS group. The histological severity of OA in BMP-M
group was signiﬁcantly lower than PBS and BMP-S group according to
the modiﬁed Mankin’s histological grading. Remarkable inﬂammation or
hyperplasia of synovium was not observed in any group.
Conclusions: Local administration of therapeutic agents to joints is
reasonable in OA which is not systemic disease. The osmotic pumps
were previously used for the maintenance of effective concentration of
therapeutic agents in the joint of animal experiments. Biodegradable
GHM was reported to achieve controlled release of growth factors in the
condition that maintained the biological activity of growth factors. The
present study showed this sustained releasing system of BMP-7 in the
joint had protective effects on OA development in an animal model. This
method might be a useful conservative treatment for human OA in the
future.
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Fig. 1. In vivo release kinematics of BMP-7.
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Purpose: Exposure of joint cartilage to blood can occur after joint trauma,
during or after major joint surgery, or due to hemophilia. This ultimately
leads to joint damage, having both the inﬂammatory characteristics
of rheumatoid arthritis and the degenerative characteristics of
osteoarthritis. It has been reported that interleukin (IL)-10 limits blood-
induced cartilage damage in vitro and that IL-4 has some cartilage
protective properties. Our aim was to study whether the combination
of IL-4 and IL-10 has an additive effect on prevention of blood-induced
cartilage damage when administered during (prevention) and after the
onset (treatment) of blood-exposure.
Methods: Human full thickness articular cartilage explants were cultured
for 4 days in the presence or absence of 50% v/v homologous blood,
mimicking a joint bleed. Either IL-4 or IL-10 alone was added (0, 10,
30, or 100ng/ml) during blood exposure (n =9 donors). Additionally,
a combination of IL-4 and IL-10 was added during blood exposure
(prevention), as well as 2, 4, 8, 24, or 48 hours after start of blood-
exposure (treatment) (n = 5 donors). After 4 days of culture the medium
was refreshed and cartilage was cultured for an additional 12 days in
the absence of additives to determine long-term effects of short-term
blood-exposure and treatment. This mimics the in vivo situation where
blood is cleared from a joint within approximately 4 days and where
IL-4 and IL-10 have short half live times. Cartilage matrix turnover, in
terms of proteoglycan synthesis, -release, and -content, was determined
at day 16.
Results: Cartilage cultured in the presence of blood decreased
proteoglycan synthesis rate, increased proteoglycan release, and
decreased proteoglycan content as measured after 16 days of culture (all
p < 0.05). This blood-induced damage to the cartilage matrix was limited
both by IL-10 and IL-4 alone in a dose-dependent way. At 10ng/ml,
IL-10 and IL-4 improved proteoglycan synthesis rate with 41% and 125%,
respectively; proteoglycan release decreased with 42% and 59%, and
proteoglycan content increased both with 19% (all p< 0.05 compared to
blood-exposure).
Most importantly, the combination of IL-4 and IL-10 (10ng/ml) was
more protective against damage caused by blood than IL-10 alone. The
decrease of proteoglycan synthesis rate due to exposure to blood was
further improved with 157%, and proteoglycan release decreased with
59% (both p < 0.05 compared to IL-10 alone).
When IL-4 plus IL-10 were added after the onset of blood-exposure, it
appeared that it had to be administered within 8 hours after start of
the bleeding to still be able to protect against blood-induced cartilage
damage. At later time points addition was ineffective.
Conclusions: Besides IL-10, as shown previously, also IL-4 protects
against blood-induced cartilage damage. This study demonstrates that
the combination of IL-4 and IL-10 is clearly more effective than the
individual components. Importantly, the protective effect is only evident
when IL-4 and Il-10 are added within 8 hours after start of blood-
exposure. This implies that treatment should be started within this time
span to prevent blood-induced cartilage damage as a result of trauma or
surgery.
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Purpose: Mesenchymal stem cells (MSCs) are a source of pluripotent
cells. They are able to self renew, differentiate into cells of mesoderm
lineage and modulate the immune response. Here we focus on
the immunomodulatory properties of MSCs for therapeutic use in
osteoarthritis. We studied the possibility to encapsulate MSCs in
alginate beads in order to achieve long-term immunomodulatory activity
of MSCs and to place them in the jointcavity. We evaluated the
expression of immunomodulatory factors by MSC upon stimulation
with inﬂammatory factors when encapsulated in alginate compared
to monolayer. Furthermore we studied the survival and differentiation
capacity of MSCs after long-term encapsulation in alginate.
Methods: Human bone marrow MSCs of two different donors were
encapsulated in 1.2% alginate or seeded in monolayer and after
preconditioning for 48 hours they were stimulated by cytokines
(50ng/mL IFNg, 50 ng/mL TNFa) for 24 hours. Each experiment was
performed in triplicate. We studied the gene expression of MSCs
compared to unstimulated control cultures. To evaluate the behavior
after long-term encapsulation the above experiment was repeated after
30 days of preculture in alginate. We also measured the amount of
DNA in a time course experiment and evaluated MSCs multi-lineage
differentiation capacities after 1 and 30 days of encapsulation in alginate
beads. Mixed model ANOVA was used to calculate statistical signiﬁcance.
A p-value <0.05 was considered statistically signiﬁcance.
Results: Stimulation with IFNg and TNFa increased the expression of
TNFa, IL1b, IL-6 (Fig1A), IDO (Fig1B) and COX2 in MSCs, whereas VEGF
was downregulated (p < 0.05). TGFb1 and TIMP2 didn’t reach signiﬁcance
but showed a trend toward downregulation after cytokine treatment.
The response of MSCs in alginate was similar to MSCs in monolayer
culture. After 30 days in alginate the amount of DNA/alginate bead was
unchanged, suggesting MSCs survive but do not proliferate in alginate.
The cells still responded to inﬂammatory cytokines by increasing the
expression of TNFa, IL1b, IL-6 (Fig1A), IDO (Fig 1B) and COX2 and
